0

Ibudilast

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP50847115
CAS50847-11-5
Structure
MDL NumberMFCD00864808
Molecular Weight230.31
InChI KeyZJVFLBOZORBYFE-UHFFFAOYSA-N
Description≥99% (HPLC), solid
SolubilityDMSO: soluble 28 mg/mL; H2O: soluble 4.5 mg/mL
Assay≥99% (HPLC)
Colorwhite
Formsolid
Size10MG, 50MG
Storage Conditions2-8°C
1

Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis

Robert J Fox, Christopher S Coffey, Robin Conwit, Merit E Cudkowicz, Trevis Gleason, Andrew Goodman, Eric C Klawiter, Kazuko Matsuda, Michelle McGovern, Robert T Naismith, Akshata Ashokkumar, Janel Barnes, etc.

N Engl J Med. 2018 Aug 30;379(9):846-855.

PMID: 30157388

1

Progressive Multiple Sclerosis

Daniel Ontaneda, Robert J Fox

Curr Opin Neurol. 2015 Jun;28(3):237-43.

PMID: 25887766

1

Signal Transduction of Improving Effects of Ibudilast on Methamphetamine Induced Cell Death

Reza Tahvilian, Komail Amini, Hossein Zhaleh

Asian Pac J Cancer Prev. 2019 Sep 1;20(9):2763-2774.

PMID: 31554375

1

The Role of Neuroimmune Signaling in Alcoholism

Fulton T Crews, Colleen J Lawrimore, T Jordan Walter, Leon G Coleman Jr

Neuropharmacology. 2017 Aug 1;122:56-73.

PMID: 28159648

1

Therapeutic Advances and Challenges in the Treatment of Progressive Multiple Sclerosis

Laura E Baldassari, Robert J Fox

Drugs. 2018 Oct;78(15):1549-1566.

PMID: 30255442

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode